Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,728,529 papers from all fields of science
Search
Sign In
Create Free Account
everolimus
Known as:
SDZ-RAD
, 40-O-(2-hydroxyethyl)-rapamycin
, 42-O-(2-Hydroxy)ethyl Rapamycin
Expand
A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
26 relations
Broader (4)
Antineoplastic Agents
Immunosuppressive Agents
Polyenes
Sirolimus
Narrower (4)
Certican
EC0565
RAD 001
Zortress
Everolimus:MCnc:Pt:Bld.dot:Qn
Everolimus:MCnc:Pt:Bld:Qn
Everolimus:Mass:Pt:Dose:Qn
In Blood
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
V. Džavík
,
A. Colombo
JACC: Cardiovascular Interventions
2014
Corpus ID: 7806164
Review
2012
Review
2012
Sequential therapy with targeted agents in patients with advanced renal cell carcinoma: optimizing patient benefit.
S. Oudard
,
R. Elaidi
Cancer Treatment Reviews
2012
Corpus ID: 6669948
Highly Cited
2011
Highly Cited
2011
Promising advances in the treatment of malignant pancreatic endocrine tumors.
R. Jensen
,
G. delle Fave
New England Journal of Medicine
2011
Corpus ID: 205076728
Pancreatic neuroendocrine tumors are classified as functional (10 to 30% of the tumors) or nonfunctional (50 to 80%).1 Functional…
Expand
Highly Cited
2010
Highly Cited
2010
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two‐year angiographic and three‐year clinical results from the SPIRIT II study
Y. Onuma
,
Shuzou Tanimoto
,
+12 authors
P. Serruys
Catheterization and cardiovascular interventions
2010
Corpus ID: 38863044
Background: Little is known about the impact of treatment with drug‐eluting stents (DES) on calcified coronary lesions. This…
Expand
Highly Cited
2006
Highly Cited
2006
Don't eat the spinach--controlling foodborne infectious disease.
D. Maki
New England Journal of Medicine
2006
Corpus ID: 41680491
Between August 19 and September 5, symptomatic enteritis from Shiga toxin–producing E. coli O157:H7 infection was reported in 199…
Expand
Highly Cited
2005
Highly Cited
2005
Gender regimes in transition in Central and Eastern Europe
G. Pascall
,
Anna Kwak
2005
Corpus ID: 152644994
Introduction: gender and the family under Communism and after Gender regimes in Central and Eastern Europe Policy and parents in…
Expand
Highly Cited
2005
Highly Cited
2005
Everolimus and Basiliximab Permit Suppression by Human CD4+CD25+ Cells in vitro
D. Game
,
M. Hernandez-Fuentes
,
R. Lechler
American Journal of Transplantation
2005
Corpus ID: 11456277
Immunosuppressive drugs are essential for the prevention of acute transplant rejection but some may not promote long‐term…
Expand
Highly Cited
2000
Highly Cited
2000
Proinflammatory Effects in Experimental Mesangial Proliferative Glomerulonephritis of the Immunosuppressive Agent SDZ RAD, a Rapamycin Derivative
C. Daniel
,
R. Ziswiler
,
B. Frey
,
M. Pfister
,
H. Marti
Nephron Experimental Nephrology
2000
Corpus ID: 40325308
Background/Aim: The new immunosuppressant SDZ RAD, a rapamycin derivative, inhibits growth factor driven cell proliferation. SDZ…
Expand
Highly Cited
1999
Highly Cited
1999
SDZ RAD inhibits cold ischemia-induced vascular remodeling.
H. Schuurman
,
C. Pally
,
G. Weckbecker
,
Walter Schuler
,
Christopher M. Bruns
Transplantation Proceedings
1999
Corpus ID: 43218319
Highly Cited
1998
Highly Cited
1998
Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model.
O. Cole
,
M. Shehata
,
K. Rigg
Transplantation Proceedings
1998
Corpus ID: 13520743
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required